Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

93.08
BATS BZX Real-Time Price
As of 3:41pm ET
 +3.12 / +3.47%
Today’s Change
11.73
Today|||52-Week Range
96.92
+109.55%
Year-to-Date
Biotech stocks bounce as regulation fears ease
Jun 26 / FT.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Top-Ranked Health Care ETFs to Buy Now
Jun 23 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
Healthcare ETF (IYH) Hits New 52-Week High
Jun 23 / Zacks.com - Paid Partner Content
Clovis Up Nearly 50% on Solid Data from Ovarian Cancer Study
Jun 20 / Zacks.com - Paid Partner Content
5 Reasons Why Biotech ETFs are Soaring
Jun 22 / Zacks.com - Paid Partner Content
Here's Why Clovis Oncology (CLVS) Stock Skyrocketed Today
Jun 19 / Zacks.com - Paid Partner Content
Clovis Oncology, Inc. (CLVS) Worth a Look: Stock Jumps 6.3%
Jun 22 / Zacks.com - Paid Partner Content
Here's Why Clovis (CLVS) Stock is Up Almost 350% in One Year
Jun 16 / Zacks.com - Paid Partner Content
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
Jun 21 / Zacks.com - Paid Partner Content
Surging Earnings Estimates Signal Good News for Clovis Oncology, Inc. (CLVS)
Jun 15 / Zacks.com - Paid Partner Content